Cytori Therapeutics reported $7.42M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Baxter International BAX:US USD 3.71B 208M
Cerus CERS:US USD 95.02M 15.74M
Cytori Therapeutics CYTX:US USD 7.42M 449K
Genocea Biosciences GNCA:US USD 18.03M 653K
Haemonetics HAE:US USD 262.18M 81.69M
Infinity Pharmaceuticals INFI:US USD 14.2M 139K
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Northwest Biotherapeutics NWBO:US USD 116.13M 17.97M
Starpharma Holdings Ltd SPL:AU AUD 10.23M 941K
Teva Pharmaceutical TEVA:IT USD 11.53B 538M